Hepapar (Energique, Inc.)


Welcome to the PulseAid listing for the Hepapar drug offered from Energique, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Energique, Inc.
NON-PROPRIETARY NAME: Carduus Marianus, Chelidonium Majus, Taraxacum Officinale, Chenopodium Anthelminticum, Hepar Suis, Lycopodium Clavatum
SUBSTANCE NAME: SILYBUM MARIANUM SEED; CHELIDONIUM MAJUS; TARAXACUM OFFICINALE; DYSPHANIA AMBROSIOIDES; PORK LIVER; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; PHOSPHORU
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2013-01-04
END MARKETING DATE: 0000-00-00


Hepapar HUMAN OTC DRUG Details:

Item DescriptionHepapar from Energique, Inc.
LABELER NAME: Energique, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 3; 3; 3; 6; 6; 12; 12; 12; 12; 12([hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL)
START MARKETING DATE: 2013-01-04
END MARKETING DATE: 0000-00-00
PRODUCT ID: 44911-0062_1c93b52b-03ca-4109-9de6-aac07a9c026e
PRODUCT NDC: 44911-0062
APPLICATION NUMBER:

Other SILYBUM MARIANUM SEED; CHELIDONIUM MAJUS; TARAXACUM OFFICINALE; DYSPHANIA AMBROSIOIDES; PORK LIVER; LYCOPODIUM CLAVATUM SPORE; MERCURIUS SOLUBILIS; SODIUM SULFATE; STRYCHNOS NUX-VOMICA SEED; PHOSPHORU Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Energique, Inc.Hepapar